サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1676624

整形外科用骨移植片の世界市場：規模、シェア、動向分析（2025年～2031年）：MedCore

Orthopedic Bone Graft Substitute Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Allograft Market, Demineralized Bone Matrix Market, and 1 more

出版日
ページ情報
英文 118 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
整形外科用骨移植片の世界市場：規模、シェア、動向分析（2025年～2031年）：MedCore
出版日: 2025年01月24日
発行: iData Research Inc.
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の骨整形外科用骨移植片（BGS）の市場規模は、2024年に約28億3,000万米ドルとなりました。同市場は4.1％のCAGRで拡大し、2031年には約37億5,000万米ドルに達すると予測されています。この市場には、整形外科、外傷、再建手術で使用される様々なタイプの骨整形外科用骨移植片が含まれます。

COVID-19の大流行により、BGSの売上は選択手術の延期により減少しました。しかし、市場は2022年までに力強く回復し、安定した成長を再開しました。低侵襲技術が、従来の骨移植術よりも合成骨やDBMベースの移植片の採用を促進しています。高齢化や外傷の増加により、整形外科手術の増加が市場の成長を後押ししています。生体工学的骨移植片の技術的進歩は、移植効率と患者の転帰を向上させています。

当レポートでは、世界の整形外科用骨移植片市場について調査し、市場の概要とともに、市場分析と予測、促進要因と抑制要因、競合情勢などを提供しています。

目次

エグゼクティブサマリー

  • 世界の整形外科用骨移植片市場概要
  • 競合分析
  • 市場セグメンテーション
  • 対象地域

イントロダクション

手技件数

  • 整形外科的骨移植手術
  • 同種移植手術
  • 脱灰骨マトリックス手術
  • 合成手技

市場概要

  • セグメント別
  • 地域別

市場分析と予測

  • 整形外科用骨移植代替品市場全体
  • 同種骨移植代替品市場
  • 脱灰骨マトリックス同種移植骨移植代替品市場
  • 合成骨移植代替品市場

件数分析

  • 同種骨移植代替件数分析
  • 脱灰骨マトリックス同種移植骨移植片件数分析
  • 人工骨移植片件数分析

促進要因と抑制要因

競合市場シェア分析

図表

LIST OF CHARTS

  • Chart 4-1: Orthopedic Bone Graft Substitute Market, Global, 2024 & 2031
  • Chart 4-2: Orthopedic Bone Graft Substitute Procedures, Global, 2024
  • Chart 4-3: Orthopedic Bone Grafting Procedures by Segment, Global, 2021- 2031
  • Chart 4-4: Orthopedic Bone Graft Substitute Device Market by Segment, Global, 2021 - 2031
  • Chart 4-5: Orthopedic Bone Graft Substitute Device Market by Region, Global, 2021 - 2031
  • Chart 4-6: Leading Competitors, Orthopedic Bone Graft Substitute Market, Global, 2024

LIST OF FIGURES

  • Figure 4-1: Orthopedic Bone Graft Substitute Regions Covered, Global (1 of 2)
  • Figure 4-2: Orthopedic Bone Graft Substitute Regions Covered, Global (2 of 2)
  • Figure 4-3: Orthopedic Bone Grafting Procedures by Segment, Global, 2021 - 2031
  • Figure 4-4: Orthopedic Bone Grafting Procedures by Region, Global, 2021 - 2031
  • Figure 4-5: Orthopedic Bone Grafting Procedures by Country, North America, 2021 - 2031
  • Figure 4-6: Orthopedic Bone Grafting Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 4-7: Orthopedic Bone Grafting Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 4-8: Orthopedic Bone Grafting Procedures by Country, Western Europe, 2021- 2031
  • Figure 4-9: Orthopedic Bone Grafting Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-10: Orthopedic Bone Grafting Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-11: Orthopedic Bone Grafting Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-12: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2021- 2031 (1 of 3)
  • Figure 4-13: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 4-14: Orthopedic Bone Grafting Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 4-15: Orthopedic Bone Grafting Procedures by Country, Africa, 2021 - 2031
  • Figure 4-16: Allograft Procedures by Region, Global, 2021- 2031
  • Figure 4-17: Allograft Procedures by Country, North America, 2021- 2031
  • Figure 4-18: Allograft Procedures by Country, Latin America, 2021- 2031 (1 of 2)
  • Figure 4-19: Allograft Procedures by Country, Latin America, 2021- 2031 (2 of 2)
  • Figure 4-20: Allograft Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-21: Allograft Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-22: Allograft Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-23: Allograft Procedures by Country, Middle East, 2021- 2031
  • Figure 4-24: Allograft Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 4-25: Allograft Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 4-26: Allograft Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 4-27: Allograft Procedures by Country, Africa, 2021- 2031
  • Figure 4-28: Demineralized Bone Matrix Procedures by Region, Global, 2021- 2031
  • Figure 4-29: Demineralized Bone Matrix Procedures by Country, North America, 2021- 2031
  • Figure 4-30: Demineralized Bone Matrix Procedures by Country, Latin America, 2021- 2031 (1 of 2)
  • Figure 4-31: Demineralized Bone Matrix Procedures by Country, Latin America, 2021- 2031 (2 of 2)
  • Figure 4-32: Demineralized Bone Matrix Procedures by Country, Western Europe, 2021 - 2031
  • Figure 4-33: Demineralized Bone Matrix Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-34: Demineralized Bone Matrix Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-35: Demineralized Bone Matrix Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-36: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2021- 2031 (1 of 3)
  • Figure 4-37: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2021- 2031 (2 of 3)
  • Figure 4-38: Demineralized Bone Matrix Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 4-39: Demineralized Bone Matrix Procedures by Country, Africa, 2021 - 2031
  • Figure 4-40: Synthetic Procedures by Region, Global, 2021 - 2031
  • Figure 4-41: Synthetic Procedures by Country, North America, 2021 - 2031
  • Figure 4-42: Synthetic Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 4-43: Synthetic Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 4-44: Synthetic Procedures by Country, Western Europe, 2021- 2031
  • Figure 4-45: Synthetic Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 4-46: Synthetic Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 4-47: Synthetic Procedures by Country, Middle East, 2021 - 2031
  • Figure 4-48: Synthetic Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 4-49: Synthetic Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 4-50: Synthetic Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 4-51: Synthetic Procedures by Country, Africa, 2021 - 2031
  • Figure 4-52: Orthopedic Bone Graft Substitute Device Market by Segment, Global, 2021 - 2031 (US$M)
  • Figure 4-53: Orthopedic Bone Graft Substitute Device Market by Region, Global, 2021 - 2031 (US$M)
  • Figure 4-54: Orthopedic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-55: Units Sold by Region, Orthopedic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-56: Average Selling Price by Region, Orthopedic Bone Graft Substitute Market, Global, 2021- 2031 (US$)
  • Figure 4-57: Market Value by Region, Orthopedic Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-58: Allograft Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-59: Units Sold by Region, Allograft Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-60: Average Selling Price by Region, Allograft Bone Graft Substitute Market, Global, 2021 - 2031 (US$)
  • Figure 4-61: Market Value by Region, Allograft Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-62: Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-63: Units Sold by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-64: Average Selling Price by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 - 2031 (US$)
  • Figure 4-65: Market Value by Region, Demineralized Bone Matrix Allograft Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-66: Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-67: Units Sold by Region, Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-68: Average Selling Price by Region, Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$)
  • Figure 4-69: Market Value by Region, Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-70: Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-71: Units Sold by Region, Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-72: Average Selling Price by Region, Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$)
  • Figure 4-73: Market Value by Region, Generation 1 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-74: Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-75: Units Sold by Region, Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031
  • Figure 4-76: Average Selling Price by Region, Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$)
  • Figure 4-77: Market Value by Region, Generation 2 Synthetic Bone Graft Substitute Market, Global, 2021 - 2031 (US$M)
  • Figure 4-78: Allograft Bone Graft Substitute Units Sold by Indication, Global, 2021 - 2031
  • Figure 4-79: Spine Allograft Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-80: Trauma Allograft Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-81: Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold, Global, 2021- 2031
  • Figure 4-82: Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication, Global, 2021 - 2031
  • Figure 4-83: Spine Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-84: Trauma Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-85: Large Joint Reconstruction Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-86: Synthetic Bone Graft Substitute Units Sold by Indication, Global, 2021 - 2031
  • Figure 4-87: Spine Synthetic Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-88: Trauma Synthetic Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-89: Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold, Global, 2021 - 2031
  • Figure 4-90: Leading Competitors, Orthopedic Bone Graft Substitute Market, Global, 2024
目次
Product Code: iDATA_GLOB25_MC_BGS

The global bone graft substitute (BGS) market was valued at approximately $2.83 billion in 2024 and is expected to grow at a CAGR of 4.1%, reaching approximately $3.75 billion by 2031. The market includes various types of bone graft substitutes used in orthopedic, trauma, and reconstructive surgeries.

The BGS market is segmented into:

  • Allograft BGS
  • Demineralized Bone Matrix (DBM) Allograft BGS
  • Synthetic BGS

The market is further categorized based on indication type:

  • Spine (Cervical, Thoracolumbar)
  • Trauma (Non-union, Fresh Fracture)
  • Large Joint Reconstruction (Hip, Knee)
  • Craniomaxillofacial
  • Oncology
  • Foot Bone Reconstructions

Market Insights

  • Unit Sales & Average Selling Prices
  • Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031
  • Recent Mergers & Acquisitions
  • Competitive Landscape
  • Company Profiles & Product Portfolios

Market Trends

  • The COVID-19 pandemic caused a decline in BGS sales due to postponed elective surgeries. However, the market recovered strongly by 2022 and resumed steady growth.
  • Minimally invasive techniques are driving the adoption of synthetic and DBM-based grafts over traditional bone grafting procedures.
  • Rising orthopedic procedures due to an aging population and increasing trauma-related injuries are fueling market growth.
  • Technological advancements in bioengineered bone grafts are increasing graft efficiency and patient outcomes.

Market Share Insights

Top Competitors in the Global Bone Graft Substitute Market (2024):

1 Medtronic

* Market leader due to a dominant share in the DBM and synthetic BGS segments.

* Grafton(R) - The first fiber-based DBM allograft BGS and one of the most widely used.

* MASTERGRAFT(R) - Synthetic BGS product line available in granules, moldable putty, flexible strip, and matrix EXT.

2 Stryker

* Second-largest competitor in the market.

* Offers multiple BGS products including Vitoss(TM), ALLOMATRIX(R), FUSIONFLEX(R), and PRO-STIM(R).

3 DePuy Synthes (Johnson & Johnson)

* Third-largest competitor in the BGS market.

* Competes with its DBX(R) DBM product line and chronOS(R) synthetic BGS.

Global Research Scope

  • Regions Covered:

* North America: United States, Canada

* Latin America: Brazil, Mexico, Chile, Colombia

* Western Europe: Germany, France, Italy, Spain, United Kingdom

* Central & Eastern Europe: Poland, Russia, Turkey

* Middle East: Saudi Arabia, UAE, Israel

* Asia Pacific: China, Japan, India, South Korea

* Africa: South Africa, Egypt, Nigeria

  • Base Year: 2024
  • Forecast Period: 2025-2031
  • Historical Data: 2021-2023

Quantitative Coverage

  • Market Size
  • Market Shares
  • Market Forecasts
  • Market Growth Rates
  • Units Sold
  • Average Selling Prices
  • Procedure Numbers

Qualitative Coverage

  • COVID-19 Impact
  • Market Growth Trends
  • Market Limiters
  • Competitive Analysis & SWOT for Top Competitors
  • Mergers & Acquisitions
  • Company Profiles
  • Product Portfolios
  • FDA Recalls
  • Disruptive Technologies
  • Disease Overviews

Data Sources

  • Primary Interviews with Industry Leaders
  • Government Physician Data
  • Regulatory Data
  • Hospital Private Data
  • Import & Export Data
  • iData Research Internal Database

TABLE OF CONTENT

  • 4.1 Executive Summary
    • 4.1.1 Global Orthopedic Bone Graft Substitute Market Overview
    • 4.1.2 Competitive Analysis
    • 4.1.3 Regions Included
  • 4.2 Introduction
  • 4.3 Procedure Numbers
    • 4.3.1 Total Orthopedic Bone Grafting Procedures
    • 4.3.2 Allograft Procedures
    • 4.3.3 Demineralized Bone Matrix Procedures
    • 4.3.4 Synthetic Procedures
  • 4.4 Market Overview
    • 4.4.1 By Segment
    • 4.4.2 By Region
  • 4.5 Market Analysis and Forecast
    • 4.5.1 Total Orthopedic Bone Graft Substitute Market
    • 4.5.2 Allograft Bone Graft Substitute Market
    • 4.5.3 Demineralized Bone Matrix Allograft Bone Graft Substitute Market
    • 4.5.4 Synthetic Bone Graft Substitute Market
      • 4.5.4.1 Synthetic Bone Graft Substitute Market by Generation Type
  • 4.6 Unit Analysis
    • 4.6.1 Allograft Bone Graft Substitute Unit Analysis
      • 4.6.1.1 Allograft Bone Graft Substitute Units Sold by Indication
      • 4.6.1.1.1 Spine Allograft Bone Graft Substitute Units Sold
      • 4.6.1.1.2 Trauma Allograft Bone Graft Substitute Units Sold
      • 4.6.1.1.3 Large Joint Reconstruction Allograft Bone Graft Substitute Units Sold
    • 4.6.2 Demineralized Bone Matrix Allograft Bone Graft Substitute Unit Analysis
      • 4.6.2.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold by Indication
      • 4.6.2.1.1 Spine Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
      • 4.6.2.1.2 Trauma Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
      • 4.6.2.1.3 Large Joint Reconstruction Demineralized Bone Matrix Allograft Bone Graft Substitute Units Sold
    • 4.6.3 Synthetic Bone Graft Substitute Unit Analysis
      • 4.6.3.1 Synthetic Bone Graft Substitute Units Sold by Indication
      • 4.6.3.1.1 Spine Synthetic Bone Graft Substitute Units Sold
      • 4.6.3.1.2 Trauma Synthetic Bone Graft Substitute Units Sold
      • 4.6.3.1.3 Large Joint Reconstruction Synthetic Bone Graft Substitute Units Sold
  • 4.7 Drivers and Limiters
    • 4.7.1 Market Drivers
    • 4.7.2 Market Limiters
  • 4.8 Competitive Market Share Analysis